Skip to main content

Innate Immunity to Mycobacterium Tuberculosis

  • Chapter
Tropical Diseases

Abstract

Although one third of the world’s population is infected with Mycobacterium tuberculosis (MTB), only 5 to 10% has a lifetime risk of developing active disease. Tuberculosis can develop either within 1-2 years after infection (primary tuberculosis) or at a later date (postprimary tuberculosis). Disease localization, severity, and outcome are highly variable. For example, miliary tuberculosis, characterized by the haematogenous dissemination of large numbers of mycobacteria throughout the body, is the most serious type of disease manifestation. In contrast, tuberculous pleuritis is usually a self-limiting disease. Tuberculosis may develop anywhere in the body, but usually presents as a pulmonary infection, ranging from mild infiltration to chronic, cavitary and severely destructive disease. The different manifestations of infection with MTB reflect the balance between bacillus and host-defence mechanisms, in which the quality of host defence determines the outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altare, F., Ensser, A., Breiman, A., Reichenbach, J., Baghdadi, J.E., Fischer, A., Emile, J.F., Gaillard JL, Meinl, E., and Casanova, J.L., 2001, Interleukin-12 receptor beta- 1-deficiency in a patient with abdominal tuberculosis. J. Infect.Dis. 184: 231–236.

    Article  PubMed  CAS  Google Scholar 

  • Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Whittle, H.C., and Hill, V., 1998, Variations in the NRAMPI gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338: 640–644.

    Article  PubMed  CAS  Google Scholar 

  • Blackwell, J.M., Searle, S., Goswami, T., and Miller, E.N., 2000, Understanding the multiple functions of Nrampl. Microbes Infect. 2: 317–321.

    Article  PubMed  CAS  Google Scholar 

  • Cervino, A.C., Lakiss, S., Sow, O., and Hill, A.V., 2000, Allelic association between the NRAMPI gene and susceptibility to tuberculosis in Guinea-Conakry. Ann. Hum. Genet. 64: 507–512.

    Article  PubMed  CAS  Google Scholar 

  • Garred, P., Richter, C., Andersen, A.B., Madsen, H.O., Mtoni, I., Svejgaard, A., and Shao, J.,1997, Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol. 46: 204–208.

    CAS  Google Scholar 

  • Hirsch, C.S., Toossi, Z., Othieno, C., Johnson, J.L., Schwander, S.K., Robertson, S., Allis, R.S., Edmonds, K., Okwera, A., Mugerwa, R., Peters, P., and Ellner, J.J., 1999, Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180: 2069–2073.

    Article  PubMed  CAS  Google Scholar 

  • Keane, J., Gershon, S., Wise, R.P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W.D., Siegel, J.N., and Braun, M.M., 2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345: 1098–1104.

    Article  PubMed  CAS  Google Scholar 

  • Ottenhoff, T.H.M., Kumararatne, D., and Casanova, J.L., 1998, Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 19: 491–494.

    Article  PubMed  CAS  Google Scholar 

  • Selvaraj, P., Narayanan, P.R., and Reetha, A.M., 1999, Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber. Lung Dis. 79: 221–227.

    Article  CAS  Google Scholar 

  • Stenger, S. and Modlin, R.L., 1999, T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2: 89–93.

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson, R.J., Patel, P., Llewelyn, M., Hirsch, C.S., Pasvol, G, Snounou, G., Davidson, R.N., and Toossi, Z., 1999, Influence of polymorphism in the genes for the interleukin (IL)- 1 receptor antagonist and IL-lbeta on tuberculosis. J. Exp. Med. 189: 1863–1874.

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G., Lalvani, A., Wright, D., Latif, M., and Davidson, R.N., 2000, Influence of vitamin D deficiency and Vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355: 618–621.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

van Crevel, R., Ottenhoff, T.H.M., van der Meer, J.W.M. (2003). Innate Immunity to Mycobacterium Tuberculosis . In: Marzuki, S., Verhoef, J., Snippe, H. (eds) Tropical Diseases. Advances in Experimental Medicine and Biology, vol 531. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0059-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0059-9_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4905-1

  • Online ISBN: 978-1-4615-0059-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics